Smeykal Megan 4
4 · TELA Bio, Inc. · Filed Feb 21, 2025
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Smeykal Megan
Chief Accounting Officer
Transactions
- Award
Common Stock
2025-02-19+9,400→ 39,479 total
Footnotes (2)
- [F1]Includes 1,079 shares acquired under the Issuer's employee stock purchase plan on July 31, 2024.
- [F2]These restricted stock units will vest in four equal annual installments beginning on February 19, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.